劉 文琪

Medicine & Life Sciences

1. Aldosterone 6%
2. Alleles 9%
3. Angiotensin Receptor Antagonists 7%
4. Angiotensin Type 1 Receptor 8%
5. Angiotensin-Converting Enzyme Inhibitors 6%
6. Bone Density 6%
7. Chronic Obstructive Pulmonary Disease 11%
8. Cohort Studies 95%
9. Comorbidity 10%
10. Confidence Intervals 25%
11. Databases 13%
12. Epidemiologic Studies 5%
13. Genetic Polymorphisms 48%
14. Health Insurance 6%
15. Hypertension 8%
16. Incidence 6%
17. Intensity-Modulated Radiotherapy 56%
18. International Classification of Diseases 13%
19. Mineralocorticoid Receptor Antagonists 8%
20. Mortality 8%
21. Mouth 62%
22. Neoplasms 20%
23. Oral Surgery 54%
24. Osteoporosis 29%
25. Osteoporotic Fractures 55%
26. Population 54%
27. Propensity Score 100%
28. Proportional Hazards Models 14%
29. Radiotherapy 51%
30. Real-Time Polymerase Chain Reaction 5%
31. Registries 12%
32. Regression Analysis 10%
33. Renin-Angiotensin System 48%
34. Software 5%
35. Software Design 9%
36. Squamous Cell Carcinoma 77%
37. Taiwan 61%
38. Uterine Cervical Neoplasms 18%